← All trials
NCT05117866
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 15, 2020
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Nov 11, 2021
- Last posted
- Nov 11, 2021
- Enrollment
- 400
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National University of IrelandLead sponsor
- National University of IrelandReponsible party - principal investigator
- Boston Scientific CorporationCollaborator
- Fujita Health UniversityOverall official - principal investigator
- Mitsui Memorial HospitalOverall official - principal investigator
- National University of IrelandStudy chair
- MeditrixCollaborator
- Fujita Health UniversityOverall official - principal investigator
- Fujita Health UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.